Latest Technology Platforms News

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

REA Group has reported a robust half-year performance for H1 FY25, with revenue climbing 20% to $873 million and net profit surging 26%, driven by strong Australian and Indian market momentum and strategic technology investments.

BlueBet Holdings Ltd has announced the acquisition of TopSport, a strategic move expected to boost its market share and profitability. The deal is supported by a $15 million equity raising to fund the upfront payment and growth initiatives.

BlueBet has announced a strategic acquisition of TopSport, supported by a $15 million equity raise, aiming to boost market share and deliver significant earnings accretion by FY26.

Xref Limited reported a solid 10% revenue increase to $10.9 million in H1 FY2025, even as a proposed acquisition by SEEK was narrowly rejected by shareholders. The company plans to continue its growth trajectory as an independent ASX-listed entity with new product launches on the horizon.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.

Thrive Tribe Technologies has strengthened its cash position through multiple capital raises and appointed Jade Spooner as its new CEO, while its Slik investment achieved profitability in Q4 2024.

Dotz Nano Limited has landed its first commercial order for DotzShield in the U.S. and made significant strides in carbon capture technology development, including a new sorbent for Direct Air Capture and a strategic collaboration with Bar-Ilan University.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.

Genetic Signatures reported a robust 190% increase in quarterly sales to $3.8 million, driven by strong respiratory testing demand in Australia and strategic UK deployments. Despite longer US sales cycles, the company maintains a solid $40.8 million cash position and advances R&D on its 3base® platform.

Origin Energy's December 2024 Quarterly Report reveals a 3% revenue increase in its Integrated Gas segment despite a slight production dip, while Octopus Energy continues rapid customer growth, becoming the UK's largest retailer.